NEW YORK (GenomeWeb News) – German firm Caprotec Bioanalytics today announced it has raised €1 million ($1.4 million) in a Series B round.
The second closing brings the total amount raised in the round to €5 million in equity, Caprotec said. The company announced it had raised €4 million in the Series B round last year.